Market Overview

CAS Medical Names John Gamelin VP of R&D

Related CASM
Pharmaceutical Stocks In Play Following Merck/Cubist Deal
Southwest Airlines Tops Q2 Earnings

CAS Medical Systems, Inc. (Nasdaq: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the promotion of John Gamelin, Ph.D., to Vice President, Research & Development. Dr. Gamelin has been with CASMED since 2009 and most recently served as Director of Research & Development.

Posted-In: News Management


Related Articles (CASM)

Around the Web, We're Loving...